In this podcast, we dive into a really important area that can significantly influence your GenAI results – Prompt Engineering and other areas.
In this podcast, we delve into the world of omnichannel strategies in Medical Affairs, where understanding your audience’s educational needs and communication preferences is pivotal for delivering relevant and engaging data dissemination.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
10 reasons digital strategies fail plus ways you and your teams can navigate between the icebergs of these failures on the way to success.
This MAPS Executive Consortium article explores ways in which Medical Affairs can help industry adapt its practices to deal with emerging issues in the transition to personalized medicine.
In this podcast, MAPS speaks with experts from Pfizer and Putnam Associates about the most exciting current uses of AI and also where we may be headed in the future.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
“I see Medical Affairs co-leading the pharmaceutical and MedTech industries into a new era of patient-centered evidence generation and communication in a valued-based world,” Kremer says.
MAPS speaks with Liz de Somer, CEO of Medicines Australia and Sharon Winton, CEO of Lymphoma Australia to explore patient engagement from the perspectives of industry and patient associations.
This podcast reviews new ways of identifying and quantifying opportunities for field medical impact with disease-state analytics.